J Korean Rheum Assoc.  2005 Sep;12(3):231-234.

Sulfasalazine-induced Megaloblastic Anemia in Normal Serum Folate Level

Affiliations
  • 1Department of Internal Medicine, Gachon Medical School Gil Medical Center, Incheon, Korea. baekhj@gilhospital.com
  • 2Department of Laboratory Medicine, Gachon Medical School Gil Medical Center, Incheon, Korea.

Abstract

Sulfasalazine produces a varied spectrum of adverse reactions on the hematopoietic system. Sulfasalazine-induced megaloblastic anemia is very rare and a few cases have been reported in patients with inflammatory bowel disease. Most of them show a low serum folate level. The pathogenesis is known as folate deficiency by intestinal folate malabsorption, inhibition of folate enzyme, or hemolysis. We experienced a 43-year old female with Behcet's disease, who presented with megaloblastic anemia having normal serum folate level after treatement of sulfasalazine (2 g/day for 3 months). Megaloblastic anemia recovered after withdrawal of the drug only.

Keyword

Sulfasalazine; Megaloblastic anemia; Serum folate level

MeSH Terms

Adult
Anemia, Megaloblastic*
Female
Folic Acid*
Hematopoietic System
Hemolysis
Humans
Inflammatory Bowel Diseases
Megaloblasts*
Sulfasalazine
Folic Acid
Sulfasalazine
Full Text Links
  • JKRA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr